Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2025-08-03

Clinical Trial Update: Effect of Topical Sinonasal Antibiotics [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating topical sinonasal antibiotics for chronic rhinosinusitis was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: United States Naval Medical Center, San Diego | Conditions: Chronic Rhinosinusitis (Diagnosis), Antibiotic Side Effect | Phase 2 | Status: WITHDRAWN